Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07018167

Enrollment

Registered

2025-06-12

Start date

2025-05-01

Completion date

2025-09-01

Last updated

2025-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction, Ischemic Attack, Transient, Stroke, Thrombolytic Therapy, Treatment Outcome

Brief summary

This study looks at how quickly stroke patients receive treatment after arriving at Gonesse Hospital and whether this affects their recovery. Researchers will measure the time between a patient's arrival and the start of clot-busting treatment (called Door-to-Needle Time), as well as the time from symptom onset to hospital arrival (Home-Time). The goal is to see if treatment delays impact recovery, and to find ways to improve stroke care in the hospital.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Patients aged 18 years or older * Confirmed diagnosis of acute ischemic stroke on imaging * Initial acute stroke care provided at Gonesse Hospital during the study period (3 months) * Intravenous thrombolysis (r-tPA) initiated at the hospital * Availability of clinical and timing data to calculate Door-to-Needle Time (DNT)

Exclusion criteria

* Patients with hemorrhagic stroke or subarachnoid hemorrhage (SAH) * Thrombolysis initiated before hospital arrival * Missing, incomplete, or unusable timing data for DNT calculation

Design outcomes

Primary

Measure	Time frame
Time (in minutes) from hospital arrival to thrombolysis (Door-to-Needle Time).	3 months

Countries

France

Outcome results